Home / Irinotecan / United States
US ATC L01CE02 · updated 2 Nov 2026
Irinotecan shortage in United States
Is there an Irinotecan shortage in United States?
Yes. As of 2 Nov 2026, 2 Irinotecan products are reported short in United States, the first since 24 Feb 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Belgium, Switzerland. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05) discontinuation | Ingenus Pharmaceuticals LLC | 24 Feb 2026 | not given | Not stated |
| US | Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02) discontinuation | Ingenus Pharmaceuticals LLC | 24 Feb 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).